{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-045904","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.341186+00:00","generated_at":"2026-05-30T00:31:24.184695+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vivos Therapeutics Q3 revenue up 17% to $3.9M; operating loss down 27%; FDA clearance for pediatric OSA","bullets":["Q3 2024 revenue $3.9M (+17% YoY); gross margin improved to 60% from 53%.","Operating loss decreased $1M (27%) YoY; operating expenses down 8% — ninth consecutive quarter of reduction.","Cash and equivalents $6.3M, stockholders' equity $7.7M; raised $4.3M via registered direct equity offering in Sept.","First FDA 510(k) clearance for treating moderate-to-severe OSA in children 6-17; AMA CPT codes for Vivos devices effective Jan 1, 2025.","Over 47,000 patients treated globally; new marketing model expanding to two more Colorado locations by early 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-045904","json":"https://secwatch.observer/filing/0001493152-24-045904.json","markdown":"https://secwatch.observer/filing/0001493152-24-045904.md","text":"https://secwatch.observer/filing/0001493152-24-045904.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224045904/0001493152-24-045904-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224045904/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:31:24.184695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}